Piquit, Yancy G.

HRN: 25-45-23  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2024
CEFUROXIME 1.5GM (VIAL)
07/06/2024
07/13/2024
INTRAVENOUS
500 Mg
Every 8 Hours
Empiric
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: